Rapamune
information and resources from the National Cancer Institute
NCI Thesaurus | Rapamune
(Other name for: sirolimus)NCI Thesaurus | Rapamune
(Other name for: sirolimus)
|
|
|
|
news articles
New Data Suggest Differences in Clinical Performance Between the ... Mar 12, 2006
Yahoo! News (press release) Sirolimus, the active drug released for the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune®. ...
Four-Year Data Suggest the CYPHER(R) Sirolimus-eluting Coronary ... Mar 11, 2006
PR Newswire (press release), Sirolimus, the active drug released for the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune(R). Rapamune is a ...
Early confusion over Medicare plan ensnares many patients Mar 14, 2006
Grand Forks Herald, After careful research, he decided on a Humana plan that promised to supply the medications, Prograf and Rapamune, which together cost nearly $2,500 a month. ...
CYPHER(R) Sirolimus-eluting Coronary Stent Benefits From Clinical ... 21 Dec 2005
PR Newswire (press release), Sirolimus, the active drug released for the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune(R). Rapamune is a ...
Transplants' cancer threat Dec 4, 2005
Richmond Times Dispatch, ...among patients who took cyclosporine, tacrolimus or similar drugs versus those treated with newer drugs called mTOR inhibitors, such as Rapamune or Rapamycin. ...
|
|
